Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma. Issue 3 (4th February 2016)

• Record Type: Journal Article
• Authors: Beasley, Richard; Pavord, Ian; Papi, Alberto; Reddel, Helen K.; Harrison, Tim; Marks, Guy B.; Hancox, Robert J.; Weatherall, Mark
• Is Part Of: European respiratory journal. Volume 47:Issue 3(2016)
• Page Start: 981
• Page End: 984
• Publication Date: 2016-02-04
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.01692-2015
• Languages: English
• ISSNs: 0903-1936

Abstract

This paper describes the rationale and design of the Novel START (Symbicort Turbuhaler Asthma Reliever Therapy) randomised controlled trial of inhaled corticosteroid (ICS)/fast-onset long-acting β-agonist (LABA) reliever therapy in mild asthma. Description of a real world study of the novel ICS/fast-onset LABA reliever therapy regimen in mild asthma http://ow.ly/WE3Yp